Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse

Trial Profile

Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Amrubicin (Primary) ; Platinum complexes
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Apr 2015 Status changed from active, no longer recruiting to completed.
    • 31 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top